Faculty Collaboration Database

Medical College of Wisconsin

CTSI Cores Search Research Informatics REDCap

Colleen A. Lawton MD

Vice Chair, Professor

Institution: Medical College of Wisconsin
Department: Radiation Oncology
Program: Clinical

Member of the Cancer Center

Send Message

Request Meeting

View Curriculum Vitae

Publications (94)

NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Postoperative Prostate Cancer. (Hall WA, Paulson E, Davis BJ, Spratt DE, Morgan TM, Dearnaley D, Tree AC, Efstathiou JA, Harisinghani M, Jani AB, Buyyounouski MK, Pisansky TM, Tran PT, Karnes RJ, Chen RC, Cury FL, Michalski JM, Rosenthal SA, Koontz BF, Wong AC, Nguyen PL, Hope TA, Feng F, Sandler HM, Lawton CAF) Int J Radiat Oncol Biol Phys 2020 Aug 27 PMID: 32861817 SCOPUS ID: 2-s2.0-85092542250 08/31/2020

First, Do No Fistulization. (Lawton CAF) Int J Radiat Oncol Biol Phys 2020 Aug 01;107(5):866 PMID: 32698976 07/24/2020

To Radiate or Not to Radiate-The Challenges of Pelvic Reirradiation. (Kamran SC, Zelefsky M, Nguyen PL, Lawton CAF) Semin Radiat Oncol 2020 Jul;30(3):238-241 PMID: 32503789 06/07/2020

A Prospective Multi-Institutional Phase I/II Trial of Step-Wise Dose-per-Fraction Escalation in Low and Intermediate Risk Prostate Cancer. (Ritter MA, Kupelian PA, Petereit DG, Lawton CA, Anger N, Geye H, Chappell RJ, Forman JD) Pract Radiat Oncol 2020 Sep - Oct;10(5):345-353 PMID: 32169590 PMCID: PMC7483248 03/15/2020

Digital Rectal Examination Remains a Key Prognostic Tool for Prostate Cancer: A National Cancer Database Review. (Borkenhagen JF, Eastwood D, Kilari D, See WA, Van Wickle JD, Lawton CA, Hall WA) J Natl Compr Canc Netw 2019 07 01;17(7):829-837 PMID: 31319388 SCOPUS ID: 2-s2.0-85070084884 07/19/2019

Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial. (Roach M, Moughan J, Lawton CAF, Dicker AP, Zeitzer KL, Gore EM, Kwok Y, Seider MJ, Hsu IC, Hartford AC, Horwitz EM, Yamoah K, Jones CU, Michalski JM, Lee WR, Pisansky TM, Rabinovitch R, Rotman M, Pryzant RM, Kim HE, Thomas CR Jr, Shipley WU, Sandler HM) Lancet Oncol 2018 11;19(11):1504-1515 PMID: 30316827 PMCID: PMC6540797 SCOPUS ID: 2-s2.0-85057161270 10/15/2018 39 Citations

Risk factors for late bowel and bladder toxicities in NRG Oncology prostate cancer trials of high-risk patients: A meta-analysis of physician-rated toxicities. (Xiao C, Moughan J, Movsas B, Konski AA, Hanks GE, Cox JD, Roach M 3rd, Zeitzer KL, Lawton CA, Peters CA, Rosenthal SA, Hsu IJ, Horwitz EM, Mishra MV, Michalski JM, Parliament MB, D'Souza DP, Pugh SL, Bruner DW) Adv Radiat Oncol 2018 Jul-Sep;3(3):405-411 PMID: 30202809 PMCID: PMC6128023 09/12/2018

Patient Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer. (Lukka HR, Pugh SL, Bruner DW, Bahary JP, Lawton CAF, Efstathiou JA, Kudchadker RJ, Ponsky LE, Seaward SA, Dayes IS, Gopaul DD, Michalski JM, Delouya G, Kaplan ID, Horwitz EM, Roach M 3rd, Pinover WH, Beyer DC, Amanie JO, Sandler HM, Kachnic LA) Int J Radiat Oncol Biol Phys 2018 10 01;102(2):287-295 PMID: 29913254 PMCID: PMC6248906 06/19/2018 15 Citations

Prostate Cancer: Improving the Flow of Research. (Lawton CAF) Radiology 2018 04;287(1):5-9 PMID: 29558314 03/21/2018 2 Citations

Magnetic Resonance Imaging-Guided Adaptive Radiation Therapy: A "Game Changer" for Prostate Treatment? (Pathmanathan AU, van As NJ, Kerkmeijer LGW, Christodouleas J, Lawton CAF, Vesprini D, van der Heide UA, Frank SJ, Nill S, Oelfke U, van Herk M, Li XA, Mittauer K, Ritter M, Choudhury A, Tree AC) Int J Radiat Oncol Biol Phys 2018 02 01;100(2):361-373 PMID: 29353654 SCOPUS ID: 2-s2.0-85041321822 01/23/2018 58 Citations

Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-Term Update of NRG Oncology RTOG 9202. (Lawton CAF, Lin X, Hanks GE, Lepor H, Grignon DJ, Brereton HD, Bedi M, Rosenthal SA, Zeitzer KL, Venkatesan VM, Horwitz EM, Pisansky TM, Kim H, Parliament MB, Rabinovitch R, Roach M 3rd, Kwok Y, Dignam JJ, Sandler HM) Int J Radiat Oncol Biol Phys 2017 06 01;98(2):296-303 PMID: 28463149 PMCID: PMC5603177 05/04/2017 36 Citations

Adjuvant radiation therapy, androgen deprivation, and docetaxel for high-risk prostate cancer postprostatectomy: Results of NRG Oncology/RTOG study 0621. (Hurwitz MD, Harris J, Sartor O, Xiao Y, Shayegan B, Sperduto PW, Badiozamani KR, Lawton CAF, Horwitz EM, Michalski JM, Roof K, Beyer DC, Zhang Q, Sandler HM) Cancer 2017 Jul 01;123(13):2489-2496 PMID: 28323339 PMCID: PMC5474197 03/23/2017 14 Citations

Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer. (Shipley WU, Seiferheld W, Lukka HR, Major PP, Heney NM, Grignon DJ, Sartor O, Patel MP, Bahary JP, Zietman AL, Pisansky TM, Zeitzer KL, Lawton CA, Feng FY, Lovett RD, Balogh AG, Souhami L, Rosenthal SA, Kerlin KJ, Dignam JJ, Pugh SL, Sandler HM, NRG Oncology RTOG) N Engl J Med 2017 02 02;376(5):417-428 PMID: 28146658 PMCID: PMC5444881 02/02/2017 250 Citations

Biomarkers of Outcome in Patients With Localized Prostate Cancer Treated With Radiotherapy. (Hall WA, Lawton CA, Jani AB, Pollack A, Feng FY) Semin Radiat Oncol 2017 01;27(1):11-20 PMID: 27986207 SCOPUS ID: 2-s2.0-85006751493 12/18/2016 4 Citations

A Hybrid Adaptive Replanning Approach for Prostate Stereotactic Body Radiation Therapy. (Ates O, Ahunbay EE, Lawton CA, Li A) Int J Radiat Oncol Biol Phys 2016 Oct 1;96(2S):E668-E669 PMID: 27675309 09/28/2016

Quality of life outcomes from a dose-per-fraction escalation trial of hypofractionation in prostate cancer. (Brower JV, Forman JD, Kupelian PA, Petereit DG, Gondi V, Lawton CA, Anger N, Saha S, Chappell R, Ritter MA) Radiother Oncol 2016 Jan;118(1):99-104 PMID: 26755165 PMCID: PMC4764419 01/13/2016 6 Citations

Watchful Waiting-Active Surveillance in Low-Risk Prostate Cancer. (Haffty BG, Lawton CA, Sandler H) JAMA Oncol 2015 Aug;1(5):688-9 PMID: 26182350 07/17/2015 1 Citation

Impact of biochemical failure classification on clinical outcome: a secondary analysis of Radiation Therapy Oncology Group 9202 and 9413. (Hamstra DA, Bae K, Hanks G, Hu C, Shipley WU, Pan CC, Roach M 3rd, Lawton CA, Sandler HM) Cancer 2015 Mar 15;121(6):844-52 PMID: 25410885 PMCID: PMC4657945 11/21/2014 2 Citations

Assessment and management of interfractional variations in daily diagnostic-quality-CT guided prostate-bed irradiation after prostatectomy. (Liu F, Ahunbay E, Lawton C, Li XA) Med Phys 2014 Mar;41(3):031710 PMID: 24593714 SCOPUS ID: 2-s2.0-84896817518 03/07/2014 14 Citations

RTOG 0518: randomized phase III trial to evaluate zoledronic acid for prevention of osteoporosis and associated fractures in prostate cancer patients. (Kachnic LA, Pugh SL, Tai P, Smith M, Gore E, Shah AB, Martin AG, Kim HE, Nabid A, Lawton CA) Prostate Cancer Prostatic Dis 2013 Dec;16(4):382-6 PMID: 24080992 PMCID: PMC3830691 SCOPUS ID: 2-s2.0-84887613817 10/02/2013 22 Citations

Practice-based evidence to evidence-based practice: building the National Radiation Oncology Registry. (Efstathiou JA, Nassif DS, McNutt TR, Bogardus CB, Bosch W, Carlin J, Chen RC, Chou H, Eggert D, Fraass BA, Goldwein J, Hoffman KE, Hotz K, Hunt M, Kessler M, Lawton CA, Mayo C, Michalski JM, Mutic S, Potters L, Rose CM, Sandler HM, Sharp G, Tomé W, Tran PT, Wall T, Zietman AL, Gabriel PE, Bekelman JE) J Oncol Pract 2013 May;9(3):e90-5 PMID: 23942508 PMCID: PMC3651578 08/15/2013 26 Citations

Prostate-specific antigen response after short-term hormone therapy plus external-beam radiotherapy and outcome in patients treated on Radiation Therapy Oncology Group study 9413. (Cury FL, Hunt D, Roach M 3rd, Shipley W, Gore E, Hsu IC, Krisch RE, Seider MJ, Sandler H, Lawton C) Cancer 2013 Jun 01;119(11):1999-2004 PMID: 23504930 PMCID: PMC3663874 SCOPUS ID: 2-s2.0-84878016620 03/19/2013 14 Citations

National Radiation Oncology Registry: The pilot prostate cancer registry. (Nassif D, Chen RC, Hoffman KE, Kuban DA, Lawton CA, Michalski JM, Potters L, Rose CM, Sandler HM, Suh W, Wall T, Zietman AL, Bekelman JE) J Clin Oncol 2012 Dec;30(34_suppl):267 PMID: 28147066 12/01/2012

Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas. (Gay HA, Barthold HJ, O'Meara E, Bosch WR, El Naqa I, Al-Lozi R, Rosenthal SA, Lawton C, Lee WR, Sandler H, Zietman A, Myerson R, Dawson LA, Willett C, Kachnic LA, Jhingran A, Portelance L, Ryu J, Small W Jr, Gaffney D, Viswanathan AN, Michalski JM) Int J Radiat Oncol Biol Phys 2012 Jul 01;83(3):e353-62 PMID: 22483697 PMCID: PMC3904368 04/10/2012 215 Citations

A research agenda for radiation oncology: results of the radiation oncology institute's comprehensive research needs assessment. (Jagsi R, Bekelman JE, Brawley OW, Deasy JO, Le QT, Michalski JM, Movsas B, Thomas CR Jr, Lawton CA, Lawrence TS, Hahn SM) Int J Radiat Oncol Biol Phys 2012 Oct 01;84(2):318-22 PMID: 22436790 03/23/2012 18 Citations

Impact of computed tomography image quality on image-guided radiation therapy based on soft tissue registration. (Morrow NV, Lawton CA, Qi XS, Li XA) Int J Radiat Oncol Biol Phys 2012 Apr 01;82(5):e733-8 PMID: 22349041 SCOPUS ID: 2-s2.0-84862816268 02/22/2012 29 Citations

Long-term results of an RTOG Phase II trial (00-19) of external-beam radiation therapy combined with permanent source brachytherapy for intermediate-risk clinically localized adenocarcinoma of the prostate. (Lawton CA, Yan Y, Lee WR, Gillin M, Firat S, Baikadi M, Crook J, Kuettel M, Morton G, Sandler H) Int J Radiat Oncol Biol Phys 2012 Apr 01;82(5):e795-801 PMID: 22330999 SCOPUS ID: 2-s2.0-84862776904 02/15/2012 38 Citations

Radiation Therapy Oncology Group (RTOG) 9413: Randomized trial comparing whole pelvic radiotherapy (WPRT) to prostate only (PORT) and neoadjuvant hormone therapy (NHT) to adjuvant hormone therapy (AHT). (Roach M, Yan Y, Lawton CA, Hsu IJ, Lustig RA, Jones CU, Rotman M, Zeitzer KL, Werner-Wasik M, Kim H, Thomas CR, Shipley WU, Sandler HM) J Clin Oncol 2012 Feb 10;30(5_suppl):96 PMID: 28143343 02/10/2012

Developing a national radiation oncology registry: From acorns to oaks. (Palta JR, Efstathiou JA, Bekelman JE, Mutic S, Bogardus CR, McNutt TR, Gabriel PE, Lawton CA, Zietman AL, Rose CM) Pract Radiat Oncol 2012 Jan-Mar;2(1):10-7 PMID: 24674031 01/01/2012

Mitigation of late renal and pulmonary injury after hematopoietic stem cell transplantation. (Cohen EP, Bedi M, Irving AA, Jacobs E, Tomic R, Klein J, Lawton CA, Moulder JE) Int J Radiat Oncol Biol Phys 2012 May 01;83(1):292-6 PMID: 22104363 PMCID: PMC3299939 SCOPUS ID: 2-s2.0-84859878438 11/23/2011 43 Citations

Consolidating risk estimates for radiation-induced complications in individual patient: late rectal toxicity. (Prior P, Devisetty K, Tarima SS, Lawton CA, Semenenko VA) Int J Radiat Oncol Biol Phys 2012 May 01;83(1):53-63 PMID: 22024204 SCOPUS ID: 2-s2.0-84859825643 10/26/2011 2 Citations

Development of an online adaptive solution to account for inter- and intra-fractional variations. (Li XA, Liu F, Tai A, Ahunbay E, Chen G, Kelly T, Lawton C, Erickson B) Radiother Oncol 2011 Sep;100(3):370-4 PMID: 21924781 SCOPUS ID: 2-s2.0-80054084236 09/20/2011 24 Citations

Validation of an online replanning technique for prostate adaptive radiotherapy. (Peng C, Chen G, Ahunbay E, Wang D, Lawton C, Li XA) Phys Med Biol 2011 Jun 21;56(12):3659-68 PMID: 21610293 SCOPUS ID: 2-s2.0-79958090578 05/26/2011 18 Citations

Long-term results of a phase II trial of ultrasound-guided radioactive implantation of the prostate for definitive management of localized adenocarcinoma of the prostate (RTOG 98-05). (Lawton CA, Hunt D, Lee WR, Gomella L, Grignon D, Gillin M, Morton G, Pisansky TM, Sandler H) Int J Radiat Oncol Biol Phys 2011 Sep 01;81(1):1-7 PMID: 21470793 PMCID: PMC3132830 04/08/2011 13 Citations

Older age predicts decreased metastasis and prostate cancer-specific death for men treated with radiation therapy: meta-analysis of radiation therapy oncology group trials. (Hamstra DA, Bae K, Pilepich MV, Hanks GE, Grignon DJ, McGowan DG, Roach M, Lawton C, Lee RJ, Sandler H) Int J Radiat Oncol Biol Phys 2011 Dec 01;81(5):1293-301 PMID: 21458924 PMCID: PMC4675045 04/05/2011 29 Citations

Evaluation of nuclear factor κB and chemokine receptor CXCR4 co-expression in patients with prostate cancer in the Radiation Therapy Oncology Group (RTOG) 8610. (Okera M, Bae K, Bernstein E, Cheng L, Lawton C, Wolkov H, Pollack A, Dicker A, Sandler H, Sweeney CJ) BJU Int 2011 Jul;108(2 Pt 2):E51-8 PMID: 21156016 PMCID: PMC3062644 12/16/2010 16 Citations

Characterizing interfraction variations and their dosimetric effects in prostate cancer radiotherapy. (Peng C, Ahunbay E, Chen G, Anderson S, Lawton C, Li XA) Int J Radiat Oncol Biol Phys 2011 Mar 01;79(3):909-14 PMID: 20732764 SCOPUS ID: 2-s2.0-79551468706 08/25/2010 47 Citations

Impact of ultrahigh baseline PSA levels on biochemical and clinical outcomes in two Radiation Therapy Oncology Group prostate clinical trials. (Rodrigues G, Bae K, Roach M, Lawton C, Donnelly B, Grignon D, Hanks G, Porter A, Lepor H, Sandler H) Int J Radiat Oncol Biol Phys 2011 Jun 01;80(2):445-52 PMID: 20615632 PMCID: PMC2952349 07/10/2010 9 Citations

To treat pelvic nodes or not? Greater testicular scatter does not explain the results of randomized trials. (Roach M 3rd, Lawton CA, Chen J) J Clin Oncol 2010 Sep 01;28(25):e450-2 PMID: 20567007 06/23/2010 5 Citations

Baseline serum testosterone in men treated with androgen deprivation therapy and radiotherapy for localized prostate cancer. (Roach M 3rd, Bae K, Lawton C, Donnelly BJ, Grignon D, Hanks GE, Porter A, Lepor H, Venketesan V, Sandler H) Int J Radiat Oncol Biol Phys 2010 Dec 01;78(5):1314-22 PMID: 20378270 PMCID: PMC2920356 04/10/2010 7 Citations

Online adaptive replanning method for prostate radiotherapy. (Ahunbay EE, Peng C, Holmes S, Godley A, Lawton C, Li XA) Int J Radiat Oncol Biol Phys 2010 Aug 01;77(5):1561-72 PMID: 20362401 SCOPUS ID: 2-s2.0-77955506120 04/07/2010 58 Citations

Follicular lymphoma transformation to dual translocated Burkitt-like lymphoma: improved disease control associated with radiation therapy. (Parker SM, Olteanu H, VanTuinen P, Lawton CA, Schultz CJ, Christians KK, Fenske TS) Int J Hematol 2009 Dec;90(5):616-622 PMID: 19937165 SCOPUS ID: 2-s2.0-73449127535 11/26/2009 9 Citations

Results of the Association of Directors of Radiation Oncology Programs (ADROP) survey of radiation oncology residency program directors. (Harris EE, Abdel-Wahab M, Spangler AE, Lawton CA, Amdur RJ) Int J Radiat Oncol Biol Phys 2009 Jun 01;74(2):327-37 PMID: 19427549 05/12/2009 11 Citations

Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer. (Michalski JM, Lawton C, El Naqa I, Ritter M, O'Meara E, Seider MJ, Lee WR, Rosenthal SA, Pisansky T, Catton C, Valicenti RK, Zietman AL, Bosch WR, Sandler H, Buyyounouski MK, Ménard C) Int J Radiat Oncol Biol Phys 2010 Feb 01;76(2):361-8 PMID: 19394158 PMCID: PMC2847420 04/28/2009 204 Citations

ACR appropriateness criteria on external beam radiation therapy treatment planning for clinically localized prostate cancer expert panel on radiation oncology--prostate. (Michalski JM, Roach M 3rd, Merrick G, Anscher MS, Beyer DC, Lawton CA, Lee WR, Pollack A, Rosenthal SA, Vijayakumar S, Carroll PR) Int J Radiat Oncol Biol Phys 2009 Jul 01;74(3):667-72 PMID: 19386445 04/24/2009 15 Citations

Hypofractionation for prostate cancer. (Ritter M, Forman J, Kupelian P, Lawton C, Petereit D) Cancer J 2009 Jan-Feb;15(1):1-6 PMID: 19197165 PMCID: PMC3039916 02/07/2009 55 Citations

A comparison of daily megavoltage CT and ultrasound image guided radiation therapy for prostate cancer. (Peng C, Kainz K, Lawton C, Li XA) Med Phys 2008 Dec;35(12):5619-28 PMID: 19175119 SCOPUS ID: 2-s2.0-56749165429 01/30/2009 23 Citations

Variation in the definition of clinical target volumes for pelvic nodal conformal radiation therapy for prostate cancer. (Lawton CA, Michalski J, El-Naqa I, Kuban D, Lee WR, Rosenthal SA, Zietman A, Sandler H, Shipley W, Ritter M, Valicenti R, Catton C, Roach M 3rd, Pisansky TM, Seider M) Int J Radiat Oncol Biol Phys 2009 Jun 01;74(2):377-82 PMID: 18947941 PMCID: PMC2905162 10/25/2008 45 Citations

RTOG GU Radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer. (Lawton CA, Michalski J, El-Naqa I, Buyyounouski MK, Lee WR, Menard C, O'Meara E, Rosenthal SA, Ritter M, Seider M) Int J Radiat Oncol Biol Phys 2009 Jun 01;74(2):383-7 PMID: 18947938 PMCID: PMC2905150 10/25/2008 238 Citations

An on-line replanning scheme for interfractional variations. (Ahunbay EE, Peng C, Chen GP, Narayanan S, Yu C, Lawton C, Li XA) Med Phys 2008 Aug;35(8):3607-15 PMID: 18777921 SCOPUS ID: 2-s2.0-48349124822 09/10/2008 90 Citations

Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer. (Horwitz EM, Bae K, Hanks GE, Porter A, Grignon DJ, Brereton HD, Venkatesan V, Lawton CA, Rosenthal SA, Sandler HM, Shipley WU) J Clin Oncol 2008 May 20;26(15):2497-504 PMID: 18413638 04/17/2008 512 Citations

Does timing of androgen deprivation influence radiation-induced toxicity? A secondary analysis of radiation therapy oncology group protocol 9413. (Taussky D, Bae K, Bahary JP, Roach M 3rd, Lawton CA, Shipley WU, Sandler HM) Urology 2008 Nov;72(5):1125-9 PMID: 18314175 03/04/2008 10 Citations

Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: long-term results of RTOG 8610. (Roach M 3rd, Bae K, Speight J, Wolkov HB, Rubin P, Lee RJ, Lawton C, Valicenti R, Grignon D, Pilepich MV) J Clin Oncol 2008 Feb 01;26(4):585-91 PMID: 18172188 01/04/2008 459 Citations

Pelvic lymph node irradiation for prostate cancer: who, why, and when? (Wang D, Lawton C) Semin Radiat Oncol 2008 Jan;18(1):35-40 PMID: 18082586 12/18/2007 15 Citations

Designing equivalent treatment regimens for prostate radiotherapy based on equivalent uniform dose. (Li XA, Wang JZ, Stewart RD, Dibiase SJ, Wang D, Lawton CA) Br J Radiol 2008 Jan;81(961):59-68 PMID: 18039721 SCOPUS ID: 2-s2.0-38449113806 11/28/2007 9 Citations

Long-term treatment sequelae after external beam irradiation with or without hormonal manipulation for adenocarcinoma of the prostate: analysis of radiation therapy oncology group studies 85-31, 86-10, and 92-02. (Lawton CA, Bae K, Pilepich M, Hanks G, Shipley W) Int J Radiat Oncol Biol Phys 2008 Feb 01;70(2):437-41 PMID: 17881145 PMCID: PMC2917176 09/21/2007 56 Citations

Adjuvant androgen deprivation therapy augments cure and long-term cancer control in men with poor prognosis, nonmetastatic prostate cancer. (Fleshner N, Keane TE, Lawton CA, Mulders PF, Payne H, Taneja SS, Morris T) Prostate Cancer Prostatic Dis 2008;11(1):46-52 PMID: 17607304 07/04/2007 8 Citations

An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions. (Lawton CA, DeSilvio M, Roach M 3rd, Uhl V, Kirsch R, Seider M, Rotman M, Jones C, Asbell S, Valicenti R, Hahn S, Thomas CR Jr) Int J Radiat Oncol Biol Phys 2007 Nov 01;69(3):646-55 PMID: 17531401 PMCID: PMC2917177 05/29/2007 340 Citations

A descriptive analysis of postimplant dosimetric parameters from Radiation Therapy Oncology Group P0019. (Lee WR, Bae K, Lawton CA, Gillin MT, Morton G, Firat S, Baikadi M, Kuettel M, Greven K, Sandler H) Brachytherapy 2006 Oct-Dec;5(4):239-43 PMID: 17118317 SCOPUS ID: 2-s2.0-33750996693 11/23/2006 15 Citations

Results of a phase II trial of transrectal ultrasound-guided permanent radioactive implantation of the prostate for definitive management of localized adenocarcinoma of the prostate (radiation therapy oncology group 98-05). (Lawton CA, DeSilvio M, Lee WR, Gomella L, Grignon D, Gillin M, Morton G, Pisansky T, Sandler H) Int J Radiat Oncol Biol Phys 2007 Jan 01;67(1):39-47 PMID: 17084551 11/07/2006 42 Citations

Quality assurance methods for the first Radiation Therapy Oncology Group permanent prostate implant protocol. (Gillin MT, Dunning BF, Lawton CA, Foley WD, Byhardt RW, Morton G, Baikadi M, Pisansky TT, Michalski JM, Ibbott G, Lopez F, Radiation Therapy Oncology Group) Brachytherapy 2006 Jul-Sep;5(3):152-6 PMID: 16864066 07/26/2006 4 Citations

Early initiation of salvage hormone therapy influences survival in patients who failed initial radiation for locally advanced prostate cancer: A secondary analysis of RTOG protocol 86-10. (Shipley WU, Desilvio M, Pilepich MV, Roach M 3rd, Wolkov HB, Sause WT, Rubin P, Lawton CA) Int J Radiat Oncol Biol Phys 2006 Mar 15;64(4):1162-7 PMID: 16427211 01/24/2006 47 Citations

Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma--long-term results of phase III RTOG 85-31. (Pilepich MV, Winter K, Lawton CA, Krisch RE, Wolkov HB, Movsas B, Hug EB, Asbell SO, Grignon D) Int J Radiat Oncol Biol Phys 2005 Apr 01;61(5):1285-90 PMID: 15817329 04/09/2005 726 Citations

Dosimetric advantages of IMRT simultaneous integrated boost for high-risk prostate cancer. (Li XA, Wang JZ, Jursinic PA, Lawton CA, Wang D) Int J Radiat Oncol Biol Phys 2005 Mar 15;61(4):1251-7 PMID: 15752907 SCOPUS ID: 2-s2.0-14844309346 03/09/2005 57 Citations

Androgen suppression plus radiation versus radiation alone for patients with stage D1/pathologic node-positive adenocarcinoma of the prostate: updated results based on national prospective randomized trial Radiation Therapy Oncology Group 85-31. (Lawton CA, Winter K, Grignon D, Pilepich MV) J Clin Oncol 2005 Feb 01;23(4):800-7 PMID: 15681524 02/01/2005 133 Citations

Ki-67 staining is a strong predictor of distant metastasis and mortality for men with prostate cancer treated with radiotherapy plus androgen deprivation: Radiation Therapy Oncology Group Trial 92-02. (Pollack A, DeSilvio M, Khor LY, Li R, Al-Saleem TI, Hammond ME, Venkatesan V, Lawton CA, Roach M 3rd, Shipley WU, Hanks GE, Sandler HM) J Clin Oncol 2004 Jun 01;22(11):2133-40 PMID: 15169799 06/01/2004 122 Citations

Hormones and radiation therapy in locally advanced adenocarcinoma of the prostate. (Lawton CA) Semin Radiat Oncol 2003 Apr;13(2):141-51 PMID: 12728443 05/03/2003 9 Citations

Prostate cancer DNA ploidy and response to salvage hormone therapy after radiotherapy with or without short-term total androgen blockade: an analysis of RTOG 8610. (Pollack A, Grignon DJ, Heydon KH, Hammond EH, Lawton CA, Mesic JB, Fu KK, Porter AT, Abrams RA, Shipley WU) J Clin Oncol 2003 Apr 01;21(7):1238-48 PMID: 12663710 03/29/2003 28 Citations

Effect of a short course of neoadjuvant hormonal therapy on the response to subsequent androgen suppression in prostate cancer patients with relapse after radiotherapy: a secondary analysis of the randomized protocol RTOG 86-10. (Shipley WU, Lu JD, Pilepich MV, Heydon K, Roach M, Wolkov HB, Sause WT, Rubin P, Lawton CA, Machtay M) Int J Radiat Oncol Biol Phys 2002 Dec 01;54(5):1302-10 PMID: 12459350 12/03/2002 56 Citations

Loss of renal function following bone marrow transplantation: an analysis of angiotensin converting enzyme D/I polymorphism and other clinical risk factors. (Juckett MB, Cohen EP, Keever-Taylor CA, Zheng Y, Lawton CA, Moulder JE, Klein J) Bone Marrow Transplant 2001 Feb;27(4):451-6 PMID: 11313676 04/21/2001 21 Citations

Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate. (Lawton CA, Winter K, Murray K, Machtay M, Mesic JB, Hanks GE, Coughlin CT, Pilepich MV) Int J Radiat Oncol Biol Phys 2001 Mar 15;49(4):937-46 PMID: 11240234 03/10/2001 356 Citations

Subset analysis of RTOG 85-31 and 86-10 indicates an advantage for long-term vs. short-term adjuvant hormones for patients with locally advanced nonmetastatic prostate cancer treated with radiation therapy. (Horwitz EM, Winter K, Hanks GE, Lawton CA, Russell AH, Machtay M) Int J Radiat Oncol Biol Phys 2001 Mar 15;49(4):947-56 PMID: 11240235 03/10/2001 101 Citations

Prostatic carcinoma. (Lawton CA, Grignon D, Newhouse JH, Schellhammer PF, Kuban DA) Radiographics 1999 Jan-Feb;19(1):185-203 PMID: 9925399 01/30/1999 2 Citations

Long-term results of selective renal shielding in patients undergoing total body irradiation in preparation for bone marrow transplantation. (Lawton CA, Cohen EP, Murray KJ, Derus SW, Casper JT, Drobyski WR, Horowitz MM, Moulder JE) Bone Marrow Transplant 1997 Dec;20(12):1069-74 PMID: 9466280 SCOPUS ID: 2-s2.0-0031437525 02/18/1998 85 Citations

Androgen suppression plus radiation versus radiation alone for patients with D1 (pN+) adenocarcinoma of the prostate (results based on a national prospective randomized trial, RTOG 85-31). Radiation Therapy Oncology Group. (Lawton CA, Winter K, Byhardt R, Sause WT, Hanks GE, Russell AH, Rotman M, Porter A, McGowan DG, DelRowe JD, Pilepich MV) Int J Radiat Oncol Biol Phys 1997 Jul 15;38(5):931-9 PMID: 9276357 07/15/1997 69 Citations

Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31. (Pilepich MV, Caplan R, Byhardt RW, Lawton CA, Gallagher MJ, Mesic JB, Hanks GE, Coughlin CT, Porter A, Shipley WU, Grignon D) J Clin Oncol 1997 Mar;15(3):1013-21 PMID: 9060541 03/01/1997

p53 status and prognosis of locally advanced prostatic adenocarcinoma: a study based on RTOG 8610. (Grignon DJ, Caplan R, Sarkar FH, Lawton CA, Hammond EH, Pilepich MV, Forman JD, Mesic J, Fu KK, Abrams RA, Pajak TF, Shipley WU, Cox JD) J Natl Cancer Inst 1997 Jan 15;89(2):158-65 PMID: 8998185 01/15/1997 148 Citations

Recombinant human interferon-beta (rHuIFN-beta) and radiation therapy for inoperable non-small cell lung cancer. (Byhardt RW, Vaickus L, Witt PL, Chang AY, McAuliffe T, Wilson JF, Lawton CA, Breitmeyer J, Alger ME, Borden EC) J Interferon Cytokine Res 1996 Nov;16(11):891-902 PMID: 8938564 SCOPUS ID: 2-s2.0-0029827192 11/01/1996 13 Citations

Results of a phase II trial of external beam radiation with etanidazole (SR 2508) for the treatment of locally advanced prostate cancer (RTOG Protocol 90-20). (Lawton CA, Coleman CN, Buzydlowski JW, Forman JD, Marcial VA, DelRowe JD, Rotman M) Int J Radiat Oncol Biol Phys 1996 Oct 01;36(3):673-80 PMID: 8948352 10/01/1996 17 Citations

Pulmonary function changes in long-term survivors of bone marrow transplantation. (Gore EM, Lawton CA, Ash RC, Lipchik RJ) Int J Radiat Oncol Biol Phys 1996 Aug 01;36(1):67-75 PMID: 8823260 SCOPUS ID: 2-s2.0-0029814113 08/01/1996 51 Citations

Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group. (Pilepich MV, Krall JM, al-Sarraf M, John MJ, Doggett RL, Sause WT, Lawton CA, Abrams RA, Rotman M, Rubin P) Urology 1995 Apr;45(4):616-23 PMID: 7716842 04/01/1995 458 Citations

Bone marrow transplant nephropathy: radiation nephritis revisited. (Cohen EP, Lawton CA, Moulder JE) Nephron 1995;70(2):217-22 PMID: 7566307 01/01/1995 85 Citations

PSA screening. (Wilson JF, Hussey DH, Lawton CA, Leibel SA, Shipley WU) J Fam Pract 1994 Sep;39(3):216-7 PMID: 7521388 09/01/1994

Prostate cancer: are racial differences in clinical stage and survival explained by differences in symptoms? (Lawton CA, Cantrell JE, Derus SW, Murray KJ, Byhardt RW, Wilson JF) Radiology 1994 Jul;192(1):37-40 PMID: 8208961 07/01/1994 8 Citations

Effect of nephrotoxic drugs on the development of radiation nephropathy after bone marrow transplantation. (Lawton CA, Fish BL, Moulder JE) Int J Radiat Oncol Biol Phys 1994 Mar 01;28(4):883-9 PMID: 8138441 03/01/1994 32 Citations

Clinical course of late-onset bone marrow transplant nephropathy. (Cohen EP, Lawton CA, Moulder JE, Becker CG, Ash RC) Nephron 1993;64(4):626-35 PMID: 8366991 01/01/1993 66 Citations

Is long-term survival possible with external beam irradiation for stage D1 adenocarcinoma of the prostate? (Lawton CA, Cox JD, Glisch C, Murray KJ, Byhardt RW, Wilson JF) Cancer 1992 Jun 01;69(11):2761-6 PMID: 1571906 06/01/1992 30 Citations

Influence of renal shielding on the incidence of late renal dysfunction associated with T-lymphocyte deplete bone marrow transplantation in adult patients. (Lawton CA, Barber-Derus SW, Murray KJ, Cohen EP, Ash RC, Moulder JE) Int J Radiat Oncol Biol Phys 1992;23(3):681-6 PMID: 1612975 01/01/1992 50 Citations

Twice-daily tapering dexamethasone treatment during cranial radiation for newly diagnosed brain metastases. (Weissman DE, Janjan NA, Erickson B, Wilson FJ, Greenberg M, Ritch PS, Anderson T, Hansen RM, Chitambar CR, Lawton CA) J Neurooncol 1991 Dec;11(3):235-9 PMID: 1726656 SCOPUS ID: 2-s2.0-0026332525 12/01/1991 38 Citations

Allogeneic bone marrow transplantation for relapsed and refractory lymphoma using genotypically HLA-identical and alternative donors. (Lundberg JH, Hansen RM, Chitambar CR, Lawton CA, Gottlieb M, Anderson T, Ash RC) J Clin Oncol 1991 Oct;9(10):1848-59 PMID: 1919635 SCOPUS ID: 2-s2.0-0025994888 10/01/1991 30 Citations

Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706. (Lawton CA, Won M, Pilepich MV, Asbell SO, Shipley WU, Hanks GE, Cox JD, Perez CA, Sause WT, Doggett SR) Int J Radiat Oncol Biol Phys 1991 Sep;21(4):935-9 PMID: 1917622 09/01/1991 348 Citations

Late renal dysfunction in adult survivors of bone marrow transplantation. (Lawton CA, Cohen EP, Barber-Derus SW, Murray KJ, Ash RC, Casper JT, Moulder JE) Cancer 1991 Jun 01;67(11):2795-800 PMID: 2025844 06/01/1991 85 Citations

Technical modifications in hyperfractionated total body irradiation for T-lymphocyte deplete bone marrow transplant. (Lawton CA, Barber-Derus S, Murray KJ, Casper JT, Ash RC, Gillin MT, Wilson JF) Int J Radiat Oncol Biol Phys 1989 Aug;17(2):319-22 PMID: 2666364 08/01/1989 30 Citations

Extended-field radiation therapy for prostatic carcinoma with para-aortic lymph node metastasis. (Lawton CA, Glisch C, Byhardt RW, Sehring S, Hartz A, Cox JD) Am J Clin Oncol 1986 Aug;9(4):302-6 PMID: 3751968 08/01/1986

Last update: 10/08/2020

© 2020 Clinical & Translational Science Institute
Medical College of Wisconsin
8701 Watertown Plank Road
Milwaukee, WI 53223

Publication and ontology data from NCBI | Disclaimer and Copyright

This site is a collaborative effort of the Medical College of Wisconsin and the Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number 8UL1TR000055) at the National Institutes of Health (NIH).

jenkins-FCD Prod-482 91ad8a360b6da540234915ea01ff80e38bfdb40a

Profiles for MCW, MU, MSOE, UWM, BCW, CW, Froedtert, and VA Faculty

Colleen A. Lawton MD

Vice Chair, Professor

Publications (94)